KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Shares Issued (2020 - 2025)

Clover Health Investments' Shares Issued history spans 6 years, with the latest figure at $541000.0 for Q4 2025.

  • For Q4 2025, Shares Issued rose 16.09% year-over-year to $541000.0; the TTM value through Dec 2025 reached $1.1 million, up 54.58%, while the annual FY2025 figure was $1.1 million, 54.58% up from the prior year.
  • Shares Issued reached $541000.0 in Q4 2025 per CLOV's latest filing, up from $192000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $283.4 million in Q4 2021 to a low of -$1.3 million in Q3 2021.
  • Average Shares Issued over 5 years is $15.0 million, with a median of $270000.0 recorded in 2023.
  • The largest YoY upside for Shares Issued was 16111.96% in 2021 against a maximum downside of 111.98% in 2021.
  • A 5-year view of Shares Issued shows it stood at $283.4 million in 2021, then crashed by 100.46% to -$1.3 million in 2022, then rose by 14.36% to -$1.1 million in 2023, then soared by 141.79% to $466000.0 in 2024, then increased by 16.09% to $541000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Shares Issued are $541000.0 (Q4 2025), $192000.0 (Q3 2025), and $148000.0 (Q2 2025).